![]() |
||||||
|
![]() | |
![]() | |
![]() | |
![]() | |
![]() | |
![]() |
Fusion gene ID: 13248 |
FusionGeneSummary for FCHO2_SLC25A17 |
![]() |
Fusion gene information | Fusion gene name: FCHO2_SLC25A17 | Fusion gene ID: 13248 | Hgene | Tgene | Gene symbol | FCHO2 | SLC25A17 | Gene ID | 115548 | 10478 |
Gene name | FCH domain only 2 | solute carrier family 25 member 17 | |
Synonyms | - | PMP34 | |
Cytomap | 5q13.2 | 22q13.2 | |
Type of gene | protein-coding | protein-coding | |
Description | F-BAR domain only protein 2FCH domain only protein 2 | peroxisomal membrane protein PMP34solute carrier family 25 (mitochondrial carrier; peroxisomal membrane protein, 34kDa), member 17 | |
Modification date | 20180523 | 20180523 | |
UniProtAcc | Q0JRZ9 | O43808 | |
Ensembl transtripts involved in fusion gene | ENST00000341845, ENST00000430046, ENST00000512348, ENST00000287761, | ENST00000491545, ENST00000435456, ENST00000402844, ENST00000544408, ENST00000542412, | |
Fusion gene scores | * DoF score | 4 X 4 X 3=48 | 5 X 2 X 7=70 |
# samples | 4 | 8 | |
** MAII score | log2(4/48*10)=-0.263034405833794 possibly effective Gene in Pan-Cancer Fusion Genes (peGinPCFGs). DoF>8 and MAII<0 | log2(8/70*10)=0.192645077942396 effective Gene in Pan-Cancer Fusion Genes (eGinPCFGs). DoF>8 and MAII>0 | |
Context | PubMed: FCHO2 [Title/Abstract] AND SLC25A17 [Title/Abstract] AND fusion [Title/Abstract] | ||
Functional or gene categories assigned by FusionGDB annotation |
* DoF score (Degree of Frequency) = # partners X # break points X # cancer types ** MAII score (Major Active Isofusion Index) = log2(# samples/DoF score*10) |
![]() |
Partner | Gene | GO ID | GO term | PubMed ID |
![]() (ChiTars (NAR, 2018), tumorfusions (NAR, 2018), Gao et al. (Cell, 2018)) * All genome coordinats were lifted-over on hg19. * Click on the break point to see the gene structure around the break point region using the UCSC Genome Browser. |
Data type | Source | Cancer type | Sample | Hgene | Hchr | Hbp | Hstrand | Tgene | Tchr | Tbp | Tstrand |
TCGA | RV | SKCM | TCGA-XV-AAZY-01A | FCHO2 | chr5 | 72251956 | + | SLC25A17 | chr22 | 41175129 | - |
* LD: Li Ding group's fusion gene list RV: Roel Verhaak group's fusion gene list ChiTaRs fusion database |
![]() * Click on the break point to see the gene structure around the break point region using the UCSC Genome Browser. |
ORF | Henst | Tenst | Hgene | Hchr | Hbp | Hstrand | Tgene | Tchr | Tbp | Tstrand |
5CDS-5UTR | ENST00000341845 | ENST00000491545 | FCHO2 | chr5 | 72251956 | + | SLC25A17 | chr22 | 41175129 | - |
5CDS-5UTR | ENST00000341845 | ENST00000435456 | FCHO2 | chr5 | 72251956 | + | SLC25A17 | chr22 | 41175129 | - |
5CDS-5UTR | ENST00000341845 | ENST00000402844 | FCHO2 | chr5 | 72251956 | + | SLC25A17 | chr22 | 41175129 | - |
5CDS-5UTR | ENST00000341845 | ENST00000544408 | FCHO2 | chr5 | 72251956 | + | SLC25A17 | chr22 | 41175129 | - |
5CDS-5UTR | ENST00000341845 | ENST00000542412 | FCHO2 | chr5 | 72251956 | + | SLC25A17 | chr22 | 41175129 | - |
5CDS-5UTR | ENST00000430046 | ENST00000491545 | FCHO2 | chr5 | 72251956 | + | SLC25A17 | chr22 | 41175129 | - |
5CDS-5UTR | ENST00000430046 | ENST00000435456 | FCHO2 | chr5 | 72251956 | + | SLC25A17 | chr22 | 41175129 | - |
5CDS-5UTR | ENST00000430046 | ENST00000402844 | FCHO2 | chr5 | 72251956 | + | SLC25A17 | chr22 | 41175129 | - |
5CDS-5UTR | ENST00000430046 | ENST00000544408 | FCHO2 | chr5 | 72251956 | + | SLC25A17 | chr22 | 41175129 | - |
5CDS-5UTR | ENST00000430046 | ENST00000542412 | FCHO2 | chr5 | 72251956 | + | SLC25A17 | chr22 | 41175129 | - |
5CDS-5UTR | ENST00000512348 | ENST00000491545 | FCHO2 | chr5 | 72251956 | + | SLC25A17 | chr22 | 41175129 | - |
5CDS-5UTR | ENST00000512348 | ENST00000435456 | FCHO2 | chr5 | 72251956 | + | SLC25A17 | chr22 | 41175129 | - |
5CDS-5UTR | ENST00000512348 | ENST00000402844 | FCHO2 | chr5 | 72251956 | + | SLC25A17 | chr22 | 41175129 | - |
5CDS-5UTR | ENST00000512348 | ENST00000544408 | FCHO2 | chr5 | 72251956 | + | SLC25A17 | chr22 | 41175129 | - |
5CDS-5UTR | ENST00000512348 | ENST00000542412 | FCHO2 | chr5 | 72251956 | + | SLC25A17 | chr22 | 41175129 | - |
5CDS-5UTR | ENST00000287761 | ENST00000491545 | FCHO2 | chr5 | 72251956 | + | SLC25A17 | chr22 | 41175129 | - |
5CDS-5UTR | ENST00000287761 | ENST00000435456 | FCHO2 | chr5 | 72251956 | + | SLC25A17 | chr22 | 41175129 | - |
5CDS-5UTR | ENST00000287761 | ENST00000402844 | FCHO2 | chr5 | 72251956 | + | SLC25A17 | chr22 | 41175129 | - |
5CDS-5UTR | ENST00000287761 | ENST00000544408 | FCHO2 | chr5 | 72251956 | + | SLC25A17 | chr22 | 41175129 | - |
5CDS-5UTR | ENST00000287761 | ENST00000542412 | FCHO2 | chr5 | 72251956 | + | SLC25A17 | chr22 | 41175129 | - |
Top |
FusionProtFeatures for FCHO2_SLC25A17 |
![]() |
Hgene | Tgene |
FCHO2 | SLC25A17 |
Functions in an early step of clathrin-mediatedendocytosis. Has both a membrane binding/bending activity and theability to recruit proteins essential to the formation offunctional clathrin-coated pits. Has a lipid-binding activity witha preference for membranes enriched in phosphatidylserine andphosphoinositides (Pi(4,5) biphosphate) like the plasma membrane.Its membrane-bending activity might be important for thesubsequent action of clathrin and adaptors in the formation ofclathrin-coated vesicles. Involved in adaptor protein complex AP-2-dependent endocytosis of the transferrin receptor, it alsofunctions in the AP-2-independent endocytosis of the LDL receptor.{ECO:0000269|PubMed:17540576, ECO:0000269|PubMed:20448150,ECO:0000269|PubMed:21762413, ECO:0000269|PubMed:22323290}. | Peroxisomal transporter for multiple cofactors likecoenzyme A (CoA), flavin adenine dinucleotide (FAD), flavinmononucleotide (FMN) and nucleotide adenosine monophosphate (AMP),and to a lesser extent for nicotinamide adenine dinucleotide(NAD(+)), adenosine diphosphate (ADP) and adenosine 3',5'-diphosphate (PAP). May catalyze the transport of free CoA, FAD andNAD(+) from the cytosol into the peroxisomal matrix by a counter-exchange mechanism. Inhibited by pyridoxal 5'-phosphate andbathophenanthroline in vitro. {ECO:0000269|PubMed:12445829,ECO:0000269|PubMed:22185573}. |
![]() * Minus value of BPloci means that the break pointn is located before the CDS. |
- In-frame and retained protein feature among the 13 regional features. |
Partner | Gene | Hbp | Tbp | ENST | Strand | BPexon | TotalExon | Protein feature loci | *BPloci | TotalLen | Protein feature | Protein feature note |
- In-frame and not-retained protein feature among the 13 regional features. |
Partner | Gene | Hbp | Tbp | ENST | Strand | BPexon | TotalExon | Protein feature loci | *BPloci | TotalLen | Protein feature | Protein feature note |
Top |
FusionGeneSequence for FCHO2_SLC25A17 |
![]() (nt: nucleotides, aa: amino acids) |
* Fusion amino acid sequences. |
* Fusion transcript sequences (only coding sequence (CDS) region). |
* Fusion transcript sequences (Full-length transcript). |
Top |
FusionGenePPI for FCHO2_SLC25A17 |
![]() |
![]() |
Hgene | Hgene's interactors | Tgene | Tgene's interactors |
FCHO2 | EPS15, DAB2, AP2M1, SLC25A41, SPC25, NPHP1, XPO1, CAPZA2, CLTB, CLTC, DBN1, MYH9, PICALM, LIMA1, GTSE1, MYO19, RHOU, PTPRG, FCHO1, AP2S1, UBC | SLC25A17 | PEX19, ILF3, ESYT2, FUT8, HNRNPU, EVPL, HNRNPUL2, UQCRB, SAMM50, HECW2, MOV10, NXF1, PTH1R, EIF3F, GNAI2, SLC39A4, SGCA, ERGIC3, TCTN3, VSIG1, TMCO3, C3AR1, SLC39A9, RANBP6, SLC39A12, LRRC8B, NPY2R, VIPR1, SCGB2A2, SLC1A1 |
![]() |
Partner | Gene | Hbp | Tbp | ENST | Strand | BPexon | TotalExon | Protein feature loci | *BPloci | TotalLen | Still interaction with |
![]() |
Partner | Gene | Hbp | Tbp | ENST | Strand | BPexon | TotalExon | Protein feature loci | *BPloci | TotalLen | Interaction lost with |
![]() |
Partner | Gene | Hbp | Tbp | ENST | Strand | BPexon | TotalExon | Protein feature loci | *BPloci | TotalLen | Interaction lost with |
Top |
RelatedDrugs for FCHO2_SLC25A17 |
![]() (DrugBank Version 5.1.0 2018-04-02) |
Partner | Gene | UniProtAcc | DrugBank ID | Drug name | Drug activity | Drug type | Drug status |
Top |
RelatedDiseases for FCHO2_SLC25A17 |
![]() (DisGeNet 4.0) |
Partner | Gene | Disease ID | Disease name | # pubmeds | Source |